SCHEMBL7543797

SCHEMBL7543797

CCCCCCCCCCCCCCCCC(=O)COCCOCCOCCOC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 5/20 0.47
KMT2A Q03164 3/20 0.46
MAPT P10636 2/20 0.46
PLA2G4B P0C869 3/20 0.44
DGKA P23743 1/20 0.44
CES1 P23141 3/20 0.42
HAO1 Q9UJM8 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 2/20 0.41
THRB P10828 1/20 0.41
HTT P42858 1/20 0.41
PPARG P37231 4/20 0.41
PPARD Q03181 4/20 0.41
PPARA Q07869 4/20 0.41
TSHR P16473 3/20 0.41
GPR84 Q9NQS5 3/20 0.41
HDAC11 Q96DB2 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7535815 1.00 CES2 (0.47) CES2KMT2AMAPTPLA2G4BDGKA
SCHEMBL21100041 0.87 KMT2A (0.52) CES2KMT2AMAPTDGKACES1
SCHEMBL8567370 0.85 CES2 (0.64) CES2KMT2AMAPTPLA2G4BDGKA
SCHEMBL11242983 0.85 CES2 (0.64) CES2KMT2AMAPTPLA2G4BDGKA
SCHEMBL14614230 0.83 CES2 (0.55) CES2KMT2AMAPTPLA2G4BDGKA
SCHEMBL5611964 0.82 KMT2A (0.58) CES2KMT2AMAPTDGKACES1
Dodecanoate SCHEMBL30912229 0.81 GPR84 (0.65) KMT2AMAPTALDH1A1MEN1PPARG
Dodecanoate SCHEMBL29267330 0.81 GPR84 (0.65) KMT2AMAPTALDH1A1MEN1PPARG
SCHEMBL26208623 0.81 CES2 (0.50) CES2KMT2AMAPTPLA2G4BDGKA
SCHEMBL25885171 0.80 CES2 (0.42) CES2KMT2AMAPTPLA2G4BDGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1200454-A1 BISPLATINUM COMPLEXES ACTIVE THROUGH THE ORAL ROUTE Novuspharma S.p.A. (IT) 2002-05-02 EP disclosed
WO-2001009149-A1 BISPLATINUM COMPLEXES ACTIVE THROUGH THE ORAL ROUTE NOVUSPHARMA S.P.A. (IT) 2001-02-08 WO disclosed